版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、石河子大學(xué)碩士學(xué)位論文VEGF及uPA在腦腫瘤的表達(dá)與臨床意義姓名:王業(yè)忠申請(qǐng)學(xué)位級(jí)別:碩士專業(yè):外科學(xué)指導(dǎo)教師:彭心宇徐啟武20050501VEGFanduPAexpressioninBrainTumoranditsClincalSignificancePostgraduate:WangYeZhong(Surgery)Advisor:ProfessorPenXinYuProfessorXuQiWuobjeet:Intrcraniall
2、ulnorisacommondiseaseinneurosurgeryofwhichmeningiomagliomametastaticbraintumoraccountforover60%AlthouIghtherecentimagingtechnologicaladvanceandmicrosurgeryhaveimprovedthediagnosisandtreatmentoftheforegoingbraintumorssome
3、problemsstillremainThedeterminationandapplicationofsuchprognosticindexesascerebromasoakagerecurrenceandcancerometastasisisthemajorprobleminclinicalpracticeRecentlymolecularbiologicalstudyonintracranialprimarytumorandmeta
4、statictumorshowsthatprognsisofbraintumoriscloselyassociatedwithvascualrendothelialgrowthfactor(VEGF)andurokinasetypeplasminogenarctivextor(uPA)inaddhinntoclinicalstage,pathologicalgradingandpefitumoralbrainedemaLittieres
5、earchhasbeendoneinthisfieldalthoughtherearesomerelevantrepots,thisstudychoosesintracranialprimaryandsubsequent,benignandmalignantmeningioma,gliomametastaticbraintumorwhosewaysofgrowthvarybutarerepresentativeTherelationbe
6、tweentheirVeGFanduPAexpressionandtheirclinicalpathologyandperitumoraledemaaredetectedandcheckedinordertoprovideguidanceforclinicaltreatmentorprognosisMethod:100patientswithmaningioma(30CaseS),metastaticbrainturnor(30case
7、s)and40patientswithgiiomawerehospitalizedinthedepartmentofneurosurgeryfromOct,1998toOct2004AllthecaseswerediagnosedaccuratelybytwopluspathologistsAccordingtoWHOGliomaGrading8CaSeswereIgrade,12casesIIgrade,10CaSeSIIIgrade
8、and10casesIVgrade100patientswerefollowedbyfollow—upstudy(in6years)1mmunohisologicalchemicaldyewasappliedtoallthetissuestobecheckedusingstreptavidinPeroxidasemethod(SPmethod)Thedeggreeofperitumoralbrainedema口TBE)wasestima
9、tedonthebasisofCTofheadand/vlRITheresultsofallthegroupswereanalyzedstatisticallyResults:Among100patientswitlbratntumorthetotalpositiverateofVEGFwhenimmanohistologicalchemicaldyewasappliedwas90%(90/100cases)whilethepositi
10、verateofVEGFwas7667%formeningioma,95%forgiiomaand9667%formetastaticbraintnlnorrespectivelyThetotalpositiverateofuPAwhenimmanohistologicalchemicaldyewasappliedwas91%(91/100cases)whilethepositiverateofuPAwas8333%formeningi
11、oma925%forgliomaand9667%formetastaticbraintumorrespectivelyThepositiverateofVEGFanduPAforgliomaandmetastaticbraintumorissignificantlyhigherthanthatofVEGFanduPAformenin舀omaandtheshowisconsistentineachtulnorVEGFanduPAcould
12、notshowin10casewithouttumorinvolvementsandnormalbraintissuesTheshowofVEGFanduPAisposisfivelycorrelatedwiththemalignancelevelofgiiomaTheshowofVEGFanduPAislowerinlowgradedgliomaandhigherinhigllgradedgliomaTheVEGFshow(50/d3
13、5%)anduPAf5%/40%showoflowgradadgliomaandhighgradedgiiomawereshowedpositivelyandshowedsignificantdifierenceBrainedemawasmostobviousinpatientswithmetastaticbraintumorlessobvinusinpatientswithgliomaandleastobviousinpatients
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 胰腺癌組織中VEGF、uPA基因表達(dá)與血管生成的關(guān)系及臨床意義.pdf
- Survivin和uPA在乳腺組織中的表達(dá)及臨床意義.pdf
- OPN及uPA mRNA在胃癌中表達(dá)及臨床意義的研究.pdf
- VEGF在喉鱗癌中的表達(dá)及臨床意義.pdf
- MIC-1、uPA蛋白在胃癌中的表達(dá)及臨床意義.pdf
- LOX、VEGF在肝細(xì)胞癌中的表達(dá)及臨床意義.pdf
- Survivin VEGF在乳腺導(dǎo)管癌的表達(dá)及臨床意義分析.pdf
- VEGF、FGF-2在喉癌中的表達(dá)及臨床意義.pdf
- uPA和VEGF-D在結(jié)直腸癌中表達(dá)的差異性和臨床意義.pdf
- β-catenin和uPA在OA患者滑膜組織中的表達(dá)及臨床意義.pdf
- VEGF-C及VEGF-D在食管鱗癌中的表達(dá)及臨床意義.pdf
- bFGF和uPA蛋白在鼻咽癌組織中的表達(dá)及臨床意義.pdf
- PISD在結(jié)直腸腫瘤中的表達(dá)及臨床意義.pdf
- RhoA、Snail、VEGF基因及蛋白在SACC中表達(dá)及臨床意義.pdf
- Ang-2、VEGF及MVD在胃癌中的表達(dá)及臨床意義.pdf
- NUMB和VEGF在原發(fā)性肝癌中的表達(dá)及臨床意義.pdf
- 中期因子、VEGF-A在卵巢上皮性腫瘤組織中的表達(dá)及其臨床意義.pdf
- EGFR和VEGF在乳腺癌中的表達(dá)及臨床意義.pdf
- RECK蛋白在皮膚黑素細(xì)胞腫瘤的表達(dá)及臨床意義.pdf
- Era蛋白在胸腺上皮腫瘤中的表達(dá)及臨床意義.pdf
評(píng)論
0/150
提交評(píng)論